These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28353144)

  • 1. Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial.
    Moradan S; Nikkhah N; Mirmohammadkhanai M
    Adv Ther; 2017 May; 34(5):1211-1220. PubMed ID: 28353144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
    Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
    Buzdar A; Douma J; Davidson N; Elledge R; Morgan M; Smith R; Porter L; Nabholtz J; Xiang X; Brady C
    J Clin Oncol; 2001 Jul; 19(14):3357-66. PubMed ID: 11454883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Sharifzadeh F; Aminimoghaddam S; Kashanian M; Fazaeli M; Sheikhansari N
    Gynecol Endocrinol; 2017 Feb; 33(2):152-155. PubMed ID: 27690687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letrozole as primary therapy for endometrial hyperplasia in young women.
    Li HZ; Chen XN; Qiao J
    Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
    Dombernowsky P; Smith I; Falkson G; Leonard R; Panasci L; Bellmunt J; Bezwoda W; Gardin G; Gudgeon A; Morgan M; Fornasiero A; Hoffmann W; Michel J; Hatschek T; Tjabbes T; Chaudri HA; Hornberger U; Trunet PF
    J Clin Oncol; 1998 Feb; 16(2):453-61. PubMed ID: 9469328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
    Buzdar AU; Jones SE; Vogel CL; Wolter J; Plourde P; Webster A
    Cancer; 1997 Feb; 79(4):730-9. PubMed ID: 9024711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects associated with high-dose continuous megestrol acetate administration in the treatment of endometrial pathology.
    Güven M; Dikmen Y; Terek MC; Ozsaran AA; Itil IM; Erhan Y
    Arch Gynecol Obstet; 2001 Nov; 265(4):183-6. PubMed ID: 11789741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice.
    Lara AC; Cândido EB; Vidigal PV; Rocha AL; Carvalho-Macedo AC; Carneiro MM; Silva-Filho AL
    Acta Cir Bras; 2016 Apr; 31(4):286-93. PubMed ID: 27168542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal trials of letrozole: a new aromatase inhibitor.
    Smith IE
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):41-4. PubMed ID: 9556791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial.
    Ibrahim MI; Moustafa RA; Abdel-Azeem AA
    Arch Gynecol Obstet; 2012 Dec; 286(6):1581-7. PubMed ID: 22829102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK.
    Nuijten M; Meester L; Waibel F; Wait S
    Pharmacoeconomics; 1999 Oct; 16(4):379-97. PubMed ID: 10623366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
    Shan W; Wang C; Zhang Z; Gu C; Ning C; Luo X; Zhou Q; Chen X
    J Gynecol Oncol; 2014 Jul; 25(3):214-20. PubMed ID: 25045434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    Stilwill SE; Cooper BC
    J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical overview of anastrozole--a new selective oral aromatase inhibitor.
    Jonat W
    Oncology; 1997; 54 Suppl 2():15-8. PubMed ID: 9394855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
    Buzdar AU; Jonat W; Howell A; Jones SE; Blomqvist CP; Vogel CL; Eiermann W; Wolter JM; Steinberg M; Webster A; Lee D
    Cancer; 1998 Sep; 83(6):1142-52. PubMed ID: 9740079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.